Christine Erikstrup Hallgreen

Christine Erikstrup Hallgreen

Associate Professor

Member of:

    ORCID: 0000-0002-7916-3915

    Publication year:
    All
    1 - 10 out of 35Page size: 10
    Sort by: 1st author
    1. Published

      Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance

      Aagaard, L., Hallgreen, Christine Erikstrup & Hansen, E. H., Nov 2016, In: International journal of obesity (2005). 40, 11, p. 1742-1747 6 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    2. Published

      Flash presentation: Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Valproates

      Abtahi, S., Pajouheshnia, R., Duran-Salinas, C., Riera-Arnau, J., Gamba, M., Alsina, E., Hallgreen, Christine Erikstrup, Limoncella, G., Bartolini, C., Holthuis, E., Martin-Perez, M., Brown, J., Sturkenboom, M., Klungel, O. & Lot, O., 2022, In: Drug Safety. 45, 10, p. 1312-1313

      Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

    3. Published

      Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study

      Abtahi, S., Pajouheshnia, R., Durán, C. E., Riera-Arnau, J., Gamba, M., Alsina, E., Hoxhaj, V., Andersen, M., Bartolini, C., Kristiansen, S. B., Brown, J., Hallgreen, C. E., Garcia-Poza, P., Gardarsdottir, H., Gini, R., Girardi, A., Holthuis, E., Huerta, C., Ibánez, L., Limoncella, G. & 8 others, Martín-Pérez, M., Paoletti, O., Roberto, G., Souverein, P., Swart, K. M. A., Wing, K., Sturkenboom, M. & Klungel, O., 2023, In: Drug Safety. 46, 7, p. 689-702

      Research output: Contribution to journal › Journal article › Research › peer-review

    4. Published

      Guidance for pediatric use in prescription information for novel medicinal products in the EU and the US

      Christiansen, H., De Bruin, M. L., Frøkjær, Sven & Hallgreen, Christine Erikstrup, 2022, In: PLoS ONE. 17, 4, 19 p., e0266353.

      Research output: Contribution to journal › Journal article › Research › peer-review

    5. Published

      Mandatory requirements for pediatric drug development in the EU and the US for novel drugs: A comparative study

      Christiansen, Helle, De Bruin, M. L. & Hallgreen, Christine Erikstrup, 2022, In: Frontiers in Medicine. 9, 11 p., 1009432.

      Research output: Contribution to journal › Journal article › Research › peer-review

    6. Published

      Status of Planned and Ongoing Paediatric Trials Investigating COVID-19 Vaccines: A Cross-Sectional Study of Paediatric Clinical Trials Planned in Agreed PIPs and/or Registered in Clinical Trial Databases

      Christiansen, H., Thirstrup, Steffen & Hallgreen, Christine Erikstrup, 2022, In: Therapeutic Innovation & Regulatory Science. 56, p. 474–482

      Research output: Contribution to journal › Journal article › Research › peer-review

    7. Published

      Impact of European Benefit-Risk reassessment procedures on drug prescribing practices in Denmark

      De Bruin, M. L. (., Hallgreen, Christine Erikstrup & Andersen, Morten, Aug 2019.

      Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

    8. In preparation

      Clinical evidence and use of extrapolation in European biosimilar marketing authorizations

      Druedahl, Louise C., Vive Nielsen, C. & Hallgreen, Christine Erikstrup, 2023, (In preparation) In: BioDrugs.

      Research output: Contribution to journal › Journal article › Research › peer-review

    9. Published

      Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis

      Durán, C. E., Riera-Arnau, J., Abtahi, S., Pajouheshnia, R., Hoxhaj, V., Gamba, M., Alsina, E., Martin-Perez, M., Garcia-Poza, P., Llorente-Garcia, A., Gonzalez-Bermejo, D., Ibánez, L., Sabaté, M., Vidal, X., Ballarín, E., Sanfélix-Gimeno, G., Rodríguez-Bernal, C., Peiró, S., García-Sempere, A., Sanchez-Saez, F. & 22 others, Ientile, V., Ingrasciotta, Y., Guarneri, C., Tanaglia, M., Tari, M., Herings, R., Houben, E., Swart-Polinder, K., Holthuis, E., Huerta, C., Gini, R., Roberto, G., Bartolini, C., Paoletti, O., Limoncella, G., Girardi, A., Hyeraci, G., Andersen, Morten, Kristiansen, S. B., Hallgreen, Christine Erikstrup, Klungel, O. & Sturkenboom, M., 2023, In: Frontiers in Pharmacology. 14, 12 p., 1207976.

      Research output: Contribution to journal › Journal article › Research › peer-review

    10. Published

      How to Measure the Impact of Pharmacovigilance Activities on Public Health?

      Gardarsdottir, H., Kant, A., De Bruin, M. L., Hallgreen, Christine Erikstrup, Dal Pan, G. & Way, D., Aug 2017, p. 31-31.

      Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

    Previous 1 2 3 4 Next

    ID: 122745397